FGF21对能量代谢的调控

成纤维细胞生长因子21（fibroblast growth factor 21,FGF21）作为一种不依赖胰岛素的血糖调节因子,目前已被看做是治疗2型糖尿病的一个潜在的新型治疗因素.大量鼠类及灵长类动物模型的实验结果显示：FGF21可通过作用于脂肪组织及胰腺来降低血糖和甘油三酯含量,从而预防饮食诱导的肥胖及胰岛素抵抗.此外,FGF21也被证明可作为一种主要的内源性调控子,在禁食和酮症时起着关键的调控作用.然而,一些临床观察实验的结果表明,临床观察实验与动物模型实验之间虽然具有一定的相似性,但也存在很多不同,因而目前FGF21在人体中的生理学作用仍不明确.     

茶多酚对营养性肥胖大鼠肝脏自由基代谢的影响

目的:探讨茶多酚对营养性肥胖大鼠肝脏自由基代谢的影响。方法:采用高脂饲料喂养,体重(200±20)g的雄性SD大鼠32只,随机分为4组(n=8),测定各组大鼠肝脏细胞O自由基和N自由基。结果:高脂饲料组大鼠肝脏超氧化物歧化酶(SOD)、过氧化氢酶(CAT)活性显著提高,茶多酚补充组丙二醛(MDA)含量比对照组及高脂饲料组显著下降;高脂饲料组大鼠肝脏TNOS、iNOS活性及NO含量显著升高,茶多酚降低了总-氧化氮合酶(TNOS)、诱导型一氧化氮合酶(iNOS)活性及NO含量。结论:高脂饲料诱导了大鼠肝脏细胞的氧化应激状态,茶多酚提高了营养性肥胖大鼠肝脏的抗氧化能力,对营养性肥胖大鼠肝脏有一定的保护作用。     

运动调控FGF21在改善肥胖相关代谢性疾病中的作用

肥胖是糖尿病、脂肪肝、心血管疾病等慢性代谢性疾病发生发展的重要风险因素。运动可以改善肥胖,对相关代谢性疾病的预防与康复具有积极作用。成纤维细胞生长因子21 (fibroblast growth factor 21,FGF21)是一种对机体能量稳态、糖脂代谢有积极调控作用的内分泌因子,是代谢性疾病预防和治疗的有效靶点之一。FGF21抵抗是机体对FGF21反应性减弱的现象,表现为靶组织生物学效应降低,机体FGF21代偿性合成增加。这可能是由FGF21受体(fibroblast growth factor receptors,FGFRs)和β-klotho蛋白(β-klotho,KLB)表达减少或敏感性降低所致。肥胖患者常出现FGF21抵抗,改善FGF21抵抗是治疗肥胖及相关代谢性疾病的新思路。运动不仅可以增加部分组织FGF21表达量,还可以刺激FGFRs与KLB的表达来敏化FGF21的作用,改善FGF21抵抗。     

6周不同强度间歇性运动对肥胖大鼠体成分的影响*

目的:探讨不同强度间歇性运动对肥胖大鼠身体机能影响,为肥胖症的防治提供依据。方法:80只SD大鼠随机分成普通膳食组(n=20)和高脂膳食组(n=60),适应性喂养8周后,筛选普通膳食大鼠8只和高脂膳食肥胖大鼠32只,用于后续实验。将实验大鼠随机分为5组(n=8):普通对照组(CS),普通饲料喂养,不做任何运动;高脂安静组(HS):高脂饲料喂养,不作任何运动;高脂持续运动组(HC):进行60 min/d×5天/周×6周;高脂长时间低频率间歇性运动组(HLL):进行30 min/次×2次/天(间歇6 h)×5天/周×6周;高脂短时间高频率间歇性运动组(HSH):进行20 min/次×3次/天(间歇3 h)×5天/周×6周,各运动组大鼠在跑台上训练强度均为25 m/min。6周后,各组大鼠称重、检测RMR、FBG、TG等生化指标,并测量体脂及肌肉重量。结果:实验前,各组大鼠之间RMR、FBG、TG指标无统计学差异(P＞0.05);HSH、HLL、HC、HS组体重均明显高于CS组(P＜0.05)。实验后,HSH、HLL、HC组RMR均明显高于HS、CS组(P＜0.05),但HSH、HLL、HC组之间无显著性差异(P＞0.05);HS组体重高于CS组(P＜0.05),HSH、HLL、HC组体重明显低于HS组(P＜0.05),但三组之间无显著性差异(P＞0.05);HSH、HLL、HC组之间PF、EF、PF/W、EF/W均明显低于HS组(P＜0.01),而三者之间无统计学差异(P＞0.05);各组大鼠GM、QF均无显著性差异(P＞0.05),HSH、HLL、HC组之间GM/W、QF/W高于HS组(P＜0.05),而HSH、HLL、HC组之间无显著性差异(P＞0.05);HSH、HLL、HC组FBG、TG均明显低于CS、HS组(P＜0.05),但与HS组差异更显著(P＜0.01),而各训练组之间无显著性差异(P＞0.05)。结论:6周不同强度间歇性运动对肥胖大鼠体成分产生了良好的干预效果,且短时间高频率间歇性运动(HSH)效果可能更好。     

不同活动、饥饿和饮食成分状态下FGF21的动力学表达

成纤维细胞生长因子21（fibroblast growth factor,FGF21）是FGF家族中的新成员．目前研究显示,FGF21是一个新的糖脂代谢调节因子,有望成为治疗糖尿病的新型药物．为探讨FGF21的生理功能,利用real-time PCR和Western印迹,检测FGF21在不同生理或病理状态下基因水平和蛋白水平的表达量变化规律．实验结果显示,在全天24 h中,小鼠肝脏中FGF21在晚18点至21点,表达量显著升高,这可能与啮齿类动物傍晚活动加强及进食习性有关|FGF21在饥饿后表达量显著升高,在饥饿后喂食FGF21的表达量下降,并且随着饥饿时间的延长,FGF21的表达量升高,说明FGF21与饥饿程度呈正相关|灌注葡萄糖后20 min内,FGF21的表达量下降,而灌注脂肪乳20 min内,FGF21的表达量上升,说明葡萄糖是FGF21的负调节因子,而脂肪乳是FGF21的正调节因子|利用谷氨酸钠造模的肥胖小鼠,肝脏中FGF21的表达量显著高于同龄对照组,说明肥胖可诱导FGF21高表达．综上所述,FGF21的表达量变化与小鼠夜间活动取食、饥饿程度、饮食中不同的成分以及肥胖有关.     

2 型糖尿病伴脂肪肝患者血浆FGF21水平与肥胖、脂代谢及胰岛素抵抗的相关性

目的:研究2型糖尿病伴脂肪肝患者血浆成纤维细胞生长因子21(FGF21)水平与肥胖、脂代谢及胰岛素抵抗的相关性,为临床诊疗提供依据。方法:选取2013年5月到2015年11月我院收治的2型糖尿病伴脂肪肝患者100例为研究组,另选取同期单纯脂肪肝患者100例为脂肪肝组,健康体检者100例为对照组,比较各组入选次日清晨FGF21、谷丙转氨酶(ALT)、谷草转氨酶(AST)、胆固醇(TC)、甘油三酯(TG)、低密度脂蛋白胆固醇(LDL-C)、高密度脂蛋白胆固醇(HDL-C)、游离脂肪酸(FFA)、体重指数(BMI)、腰臀比(WHR)、空腹胰岛素(FINS)、空腹血糖(FBG)以及胰岛素抵抗指数(HOMA-IR)。结果:研究组TG、TC、AST、ALT、LDL-C、FFA、FBG、BMI、WHR、FINS、HOMA-IR以及FGF21均显著高于对照组,HDL-C显著低于对照组,比较差异具有统计学意义(P0.05);研究组FFA、TG、FINS、FBG、HOMA-IR以及FGF21显著高于脂肪肝组,BMI和WHR显著低于脂肪肝组,比较差异具有统计学意义(P0.05);相关性分析显示:FGF21与TG、FFA、BMI以及HOMA-IR呈正相关关系(P0.05)。结论:2型糖尿病合并脂肪肝患者FGF21水平会显著升高,且与脂肪代谢、肥胖以及胰岛素抵抗有关。     

成纤维细胞生长因子21对糖脂代谢调控的研究进展

成纤维细胞生长因子21(FGF21)是成纤维细胞生长因子(FGF)家族中的一员。由于它在改善能量代谢方面的积极作用,近年来获得了广泛的关注。FGF21可作用于多个组织参与调控糖脂代谢:减轻体重,改善肥胖、糖尿病等病理情况下的高血糖及高血脂;此外,FGF21在调节饥饿等特殊生理状态的能量代谢中也起着重要的作用。本文就FGF21调控糖脂代谢的研究进展作一综述,以便更好地理解其作用机制,为慢性代谢性疾病的防治提供依据。     

不同运动方式对肥胖青少年减肥效果的比较

目的：比较中等强度的有氧运动和高强度间歇性运动两种运动方式对肥胖青少年的减肥效果。方法：将40名受试者平均分成两组（n=20）：中等强度有氧运动组和高强度的间歇性运动组,分别进行9周的中等强度有氧运动和高强度的间歇性运动。试验前后分别对两组受试者身体形态指标、血液指标测试并进行比较。结果：试验后两组受试者身体形态指标明显下降（P < 0.05）,高强度间歇运动组在运动后腹部内脏脂肪面积、腹部皮下脂肪面积明显低于有氧运动组（P < 0.05）;中等强度有氧运动组胰岛素（FIN）、总胆固醇（TC）、低密度脂蛋白（LDL-C）与试验前相比显著下降（P < 0.05）,且有氧运动组TC明显低于高强度间歇性运动实验后值（P < 0.05）;高强度间歇性运动组FIN、LDL-C与试验前相比显著下降（P < 0.05）。结论：9周中等强度的有氧运动和高强度间歇性运动均能起到良好的减肥效果,高强度间歇性运动对内脏的减脂效果更好,但在胆固醇降低方面不如高强度间歇性运动组。     

耐力运动对饮食性肥胖大鼠体脂影响的研究

耐力运动对饮食性肥胖大鼠体脂影响的研究王从容,谭健,杨锡让（北京体育大学生理学教研室北京１０００８４）本实验利用与人类肥胖相近的高脂饲料诱发肥胖大鼠模型￣［２］,探讨饮食性肥胖大鼠肥胖与血脂、血糖及血胰岛素变化的关系,以及耐力训练对肥胖鼠体脂含量的影...     

FGF21代谢调节机制的研究进展

代谢综合征在全世界广泛流行,我国代谢综合征的发病率已达24.2%。代谢综合征是糖尿病和心血管疾病发病的危险因素。成纤维细胞生长因子21(fibroblast growth factor 21,FGF21)是一种代谢信号调节蛋白,外源性FGF21类似物具有降低血糖、血脂和体重等多种药理作用,但FGF21调节代谢的机制目前仍不明确,可能涉及脂联素依赖途径、非脂联素依赖途径和大脑中枢调节途径等。临床研究发现,高水平的FGF21与代谢综合征的发生、发展和不良预后密切相关,存在“FGF21抵抗”。本文旨在概述FGF21代谢调节机制的最新研究进展,以期为代谢性疾病的临床诊疗和研究提供新思路。     

Effect of high-intensity exercise and high-fat diet on lipid metabolism in the liver of rats

[Purpose]

This study investigated the effects of high-intensity exercise (Ex) and high dietary fat intake on lipid metabolism in the liver of rats.

[Methods]

Male Sprague-Dawley rats were randomly assigned to one of the four groups (n=10 per group) that were maintained on a normal diet (ND) or high-fat diet (HFD) consisting of 30% fat (w/w), with or without exercise on a treadmill at 30 m/min and 8% grade) for 4 weeks (i.e., ND, ND+Ex, HFD, and HFD+Ex groups).

[Results]

Body weight (p<.001), total plasma cholesterol (TC) (p<.001), triglyceride (TG) (p<.05), and liver TG levels (p<.05) were increased in the HFD group relative to the ND groups, and serum glucose (p<.05), insulin (p<.05), homeostatic model assessment of insulin resistance (HOMA-IR) (p<.01), and liver TG levels (p<.01) were also higher in the HFD group compared to the ND+Ex group. Plasma free fatty acid was elevated in the HFD+Ex group compared to the HFD group (p<.01). With the exception of acetyl coenzyme A carboxylase, the expression of lipid metabolism-related genes in the liver was altered in the Ex groups compared to the control group (p<.05), with genes involved in lipolysis specifically up regulated in the HFD+Ex group compared to the other groups.

[Conclusion]

Vigorous exercise may increase glucose utilization and fat oxidation by activating genes in the liver that are associated with lipid metabolism compared to that in animals consuming a HFD without exercise. Therefore, high intensity exercise can be considered to counter the adverse effects of high dietary fat intake.     

FGF21 deletion exacerbates diabetic cardiomyopathy by aggravating cardiac lipid accumulation

Fibroblast growth factor 21 (FGF21) plays an important role in energy homoeostasis. The unaddressed question of FGF21's effect on the development and progression of diabetic cardiomyopathy (DCM) is investigated here with FGF21 knockout (FGF21KO) diabetic mice. Type 1 diabetes was induced in both FGF21KO and C57BL/6J wild‐type (WT) mice via streptozotocin. At 1, 2 and 4 months after diabetes onset, the plasma FGF21 levels were significantly decreased in WT diabetic mice compared to controls. There was no significant difference between FGF21KO and WT diabetic mice in blood glucose and triglyceride levels. FGF21KO diabetic mice showed earlier and more severe cardiac dysfunction, remodelling and oxidative stress, as well as greater increase in cardiac lipid accumulation than WT diabetic mice. Western blots showed that increased cardiac lipid accumulation was accompanied by further increases in the expression of nuclear factor (erythroid‐derived 2)‐like 2 (Nrf2) and its target protein CD36, along with decreases in the phosphorylation of AMP‐activated protein kinase and the expression of hexokinase II and peroxisome proliferator‐activated receptor gamma co‐activator 1α in the heart of FGF21KO diabetic mice compared to WT diabetic mice. Our results demonstrate that FGF21 deletion‐aggravated cardiac lipid accumulation is likely mediated by cardiac Nrf2‐driven CD36 up‐regulation, which may contribute to the increased cardiac oxidative stress and remodelling, and the eventual development of DCM. These findings suggest that FGF21 may be a therapeutic target for the treatment of DCM.     

FGF21 treatment ameliorates alcoholic fatty liver through activation of AMPK-SIRT1 pathway

Fibroblast growth factor 21 （FGF21）, a recently identified member of the FGF superfamily, is mainly secreted from the liver and adipose tissues and plays an important role in improving metabolic syndrome and homeostasis. The aim of this study is to evaluate the role of FGF21 in alcoholic fatty liver disease （AFLD） and to determine if it has a therapeutic effect on AFLD. In this paper, we tested the effect of FGF21 on alcohol-induced liver injury in a murine model of chronic ethanol gavage and alcohol-treated HepG2 cells. Male KM mice received single dose of 5 g/kg ethanol gavage every day for 6 weeks, which induced sig- nificant fatty liver and liver injury. The alcohol-induced fatty liver cell model was achieved by adding ethanol into the medium of HepG2 cell cultures at a final concentration of 75 mM for 9 days. Results showed that treatment with recombinant FGF21 ameliorated alcoholic fatty liver and liver injury both in a murine model of chronic ethanol gavage and alcohol-treated HepG2 cells. In addition, FGF21 treatment down-regulated the hepatic expression of fatty acid synthetic key enzyme, activated hepatic AMPK- SIRT1 pathway and significantly down-regulated hepatic oxidative stress protein. Taken together, FGF21 corrects multiple metabolic parameters of AFLD in vitro and in vivo by activation of the AMPK-SIRT1 pathway.     

FGF21 mediates the lipid metabolism response to amino acid starvation

Lipogenic gene expression in liver is repressed in mice upon leucine deprivation. The hormone fibroblast growth factor 21 (FGF21), which is critical to the adaptive metabolic response to starvation, is also induced under amino acid deprivation. Upon leucine deprivation, we found that FGF21 is needed to repress expression of lipogenic genes in liver and white adipose tissue, and stimulate phosphorylation of hormone-sensitive lipase in white adipose tissue. The increased expression of Ucp1 in brown adipose tissue under these circumstances is also impaired in FGF21-deficient mice. Our results demonstrate the important role of FGF21 in the regulation of lipid metabolism during amino acid starvation.     

FGF21 mediates alcohol-induced adipose tissue lipolysis by activation of systemic release of catecholamine in mice

Alcohol consumption leads to adipose tissue lipoatrophy and mobilization of FFAs, which contributes to hepatic fat accumulation in alcoholic liver disease. This study aimed to investigate the role of fibroblast growth factor (FGF)21, a metabolic regulator, in the regulation of chronic-binge alcohol-induced adipose tissue lipolysis. FGF21 KO mice were subjected to chronic-binge alcohol exposure, and epididymal white adipose tissue lipolysis and liver steatosis were investigated. Alcohol exposure caused adipose intracellular cAMP elevation and activation of lipolytic enzymes, leading to FFA mobilization in both WT and FGF21 KO mice. However, alcohol-induced systemic elevation of catecholamine, which is known to be a major player in adipose lipolysis by binding to the β-adrenergic receptor, was markedly inhibited in KO mice. Supplementation with recombinant human FGF21 to alcohol-exposed FGF21 KO mice resulted in an increase in fat loss in parallel with an increase of circulating norepinephrine concentration. Furthermore, alcohol consumption-induced fatty liver was blunted in the KO mice, indicating an inhibition of fatty acid reverse transport from adipose to the liver in the KO mice. Taken together, our studies demonstrate that FGF21 KO mice are protected from alcohol-induced adipose tissue excess-lipolysis through a mechanism involving systemic catecholamine release.     

不同强度运动结合白藜芦醇对老年肥胖大鼠RBP4的影响

目的：探讨不同强度运动结合白藜芦醇对老年肥胖大鼠内脏脂肪组织视黄醇结合蛋白4（RBP4） mRNA蛋白表达及血浆RBP4浓度的影响。方法：选择鼠龄3周的雄性SD大鼠80只,随机分为对照组和实验组：对照组（C）饲喂6.0%脂肪的普通饲料（n=12）;实验组分3个阶段饲喂36%~40%高脂饲料（n=68）。建立老年肥胖大鼠模型,选取24只建模成功的肥胖大鼠随机分为4组（n=6）：肥胖对照组（CO）、白藜芦醇组（RO）、低强度运动+白藜芦醇组（LRO）、中强度运动+白藜芦醇组（MRO）。LRO组和MRO组的运动强度分别为（12 m/min×15 min）和（15 m/min×15 min）,每天运动60 min;补充白藜芦醇各组52.5 mg/kg·d灌胃1次,对照组采用等量的纯净水灌胃,持续干预8周。8周后采血和肾周、睾周、血管及内脏脂肪组织,检测血糖和血浆RBP4浓度、计算胰岛素敏感性（ISI）,检测RBP4 mRNA和蛋白表达。结果：与正常组比较,模型组大鼠RBP4 mRNA和蛋白表达、血浆浓度及血糖指标明显升高（P<0.05,P<0.01）,ISI明显降低（P<0.05）;与模型组比较,RO、LRO组和MRO组大鼠RBP4 mRNA和蛋白表达、血浆浓度及血糖指标明显降低（P<0.05,P<0.01）,ISI明显升高（P<0.05）;RO、LRO组和MRO组之间比较,MRO组大鼠RBP4 mRNA和蛋白表达、血浆浓度及血糖指标明显降低,ISI明显升高,但无显著差异。结论：不同强度运动结合白藜芦醇能降低老年肥胖大鼠内脏脂肪组织RBP4 mRNA和蛋白表达及血浆RBP4浓度,受运动强度影响较小。     

Effects of altered photoperiod on circadian clock and lipid metabolism in rats

Disruption of circadian clock timekeeping due to changes in the photoperiod enhances the risk of lipid metabolism disorders and metabolic syndrome. However, the effects of altered photoperiods on the circadian clock and lipid metabolism are not well understood. To explore the effects of altered photoperiods, we developed a rat model where rats were exposed to either short-day or long-day conditions. Our findings demonstrated that altered photoperiods mediated circadian clocks by partly disrupting rhythmicity and shifting phase values of clock genes. We also showed that compared to long-day conditions, rats under short-day conditions exhibited more photoperiodic changes in a variety of physiological outputs related to lipid metabolism, such as significant increases in serum triglyceride (TG), high-density lipoprotein, and leptin levels, as well as increased body weight, fat:weight ratio, and hepatic TG levels. These increments were gained possibly through upregulated expression of forkhead box O1 (FoxO1), which partly mediates the expression of peroxisome proliferator-activated receptorα (PPARα) to increase the expression of phosphoenolpyruvate carboxykinase (PEPCK), peroxisome proliferator-activated receptor-g coactivator-1β (PGC1β), and fatty acid synthase (Fasn). In addition, the oscillation rhythms of FoxO1, PEPCK, PGC1β, and Fasn expression levels in the livers of rats exposed to a short-day photoperiod were more robust than those exposed to a long-day photoperiod. These findings suggest that a change in photoperiod can partly disrupt the circadian rhythmcity of clock genes, impair lipid metabolism, and promote obesity.